Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke
- PMID: 11559501
- PMCID: PMC7974585
Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke
Abstract
Background and purpose: Clinicians are insecure reading CT scans by using the one-third rule for acute middle cerebral artery stroke (1/3 MCA rule) before treating patients with recombinant tissue plasminogen activator. The 1/3 MCA rule is a poorly defined volumetric estimate of the size of cerebral infarction of the MCA. A 10-point quantitative topographic CT scan score, the Alberta Stroke Program Early CT Score (ASPECTS), is described and illustrated. A sharp increase in dependence and death occurs with an ASPECTS of 7 or less. We describe how to use ASPECTS and why it works with CT scans obtained on all commonly used axial baselines. We also describe interobserver reliability among clinicians from different specialties and with different experience in reading CT scans in the context of acute stroke.
Methods: The six physicians who developed ASPECTS answered a questionnaire on precisely how they interpret and use ASPECTS. The ASPECTS areas as interpreted by these physicians were compared with one another and with standards in the literature. kappa statistics were used to assess the interobserver reliability of ASPECTS versus the 1/3 MCA rule.
Results: The exact methods of interpretation varied among the six individual observers, with either a 3:3 or 4:2 split on the specific questions. The overall interobserver agreement was good compared with that of the 1/3 MCA rule. Normal anatomic vascular and interobserver variations explain why ASPECTS can be applied with different CT axial baselines.
Conclusion: ASPECTS is a systematic, robust, and practical method that can be applied to different axial baselines. Clinician agreement is superior to that of the 1/3 MCA rule.
Figures
References
-
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute hemisphere stroke. N Engl J Med 1995;333:1581-1587 - PubMed
-
- Hacke W, Kaste M, Fieschi et al. The European Cooperative Acute Stroke Study (ECASS): safety and efficacy of intravenous thrombolysis with a recombinant tissue plasminogen activator in the treatment of acute hemisphere stroke. JAMA 1995;274:1017-1025 - PubMed
-
- Hacke W, Kaste M, Fieschi C, for the ECASS II Group. Randomized double blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke. Lancet 1998;352:1245-1251 - PubMed
-
- von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333 - PubMed
-
- Dippel DW, Du Ry van Beest Holle M, van Kooten F, Koudstaal PJ. The validity and reliability of signs of early infarction on CT in acute ischaemic stroke. Neuroradiology 2000;42:629-633 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical